Clinical Trial Update: Preventing High Blood Sugar in People Being Treated for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial to prevent high blood sugar in patients being treated for metastatic breast cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer, Breast Cancer Stage IV | Phase 2 | Status: ACTIVE_NOT_RECRUITING